This content is only available within our institutional offering.

06 Sep 2017
PANMURE: Interim results Traumakine Phase III timing

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
PANMURE: Interim results Traumakine Phase III timing
Faron Pharmaceuticals Oy (FARN:LON) | 175 -13.1 (-4.1%) | Mkt Cap: 198.7m
- Published:
06 Sep 2017 -
Author:
Julie Simmonds -
Pages:
5 -